- Category: Articles
Entering APAC Isn’t Usually a Market Entry Challenge. It’s a Capability Challenge.
For multinational healthcare and life sciences organisations, Australia and the broader APAC region can look deceptively straightforward from a distance. The organisation may already have products, established processes, international infrastructure and experienced leadership. Markets have been entered before. Commercial operations already exist elsewhere. The business understands what success looks like in Europe or North America and assumes it can replicate much of that model in another geography.
What makes expansion into Australia and APAC interesting is that the challenge is often less about entering a market and more about understanding what capability needs to exist locally for the market to succeed.
The distinction becomes important surprisingly quickly. Many multinational organisations begin expansion discussions by focusing on structure. A Country Manager is appointed. A General Manager is identified. Reporting lines are agreed. Budgets are approved. On paper, the organisation appears ready to establish itself locally.
The reality is that a title rarely answers the more important organisational questions.
What decisions need to be made locally?
Which decisions will continue to sit with regional or global leadership?
How much commercial authority should exist within the market?
What expertise needs to be present on the ground and what can effectively remain centralised?
How much capability should be built now and how much should follow as the operation develops?
These questions are often more influential than the appointment itself.
One of the patterns we see repeatedly is the assumption that establishing a local leader creates a local organisation. In reality, a Country Manager or General Manager inherits whatever structure sits around them. If key commercial, medical, market access, regulatory or operational decisions remain elsewhere, then the effectiveness of the local leader depends heavily on how well those relationships function. If too much capability is centralised, local execution can become difficult. If too much capability is built locally too early, the organisation can end up carrying complexity before it genuinely needs it.
Neither approach is inherently wrong. The challenge is understanding what the market requires rather than applying a structure that was successful somewhere else.
What often surprises multinational organisations is how different capability needs can be, even when products, customers and commercial objectives appear similar. A market may require greater emphasis on reimbursement and market access than commercial execution. Stakeholder engagement may become more important than direct sales activity. Medical affairs may carry greater influence than marketing capability. The sequence in which capability is introduced can therefore have a significant impact on the speed and success of expansion.
This is particularly visible when organisations appoint a local leader before deciding how much authority that person will genuinely have. The role sounds substantial. The mandate appears broad. Yet key decisions continue requiring approval elsewhere in the business. The individual may have responsibility for outcomes without corresponding influence over the factors that determine those outcomes.
The issue is rarely the person. More often it reflects an organisation still working through what local leadership actually means.
The strongest multinational organisations tend to spend considerable time understanding which capability needs to be close to the market and which capability benefits from remaining centralised. They recognise that local presence and local capability are not necessarily the same thing. A market can have a leader without having all critical expertise locally. Equally, an organisation can possess substantial capability in-market while still relying on regional or global decision-making structures.
The conversation therefore becomes less about geography and more about ownership. Which decisions belong in-market? Which relationships need to be developed locally? Which functions create the greatest value when they sit close to customers, clinicians, payers, providers or regulators? Once those questions are answered, the leadership structure tends to become much clearer.
This thinking also changes the way organisations approach hiring. Rather than beginning with an organisational chart, the process begins with understanding how the market will operate. A company entering Australia may discover that market access capability is critical far earlier than expected. Another may realise that medical leadership will shape commercial outcomes more profoundly than additional sales infrastructure. A third may find that the priority is not another executive but specialist capability capable of helping the organisation navigate a particular stage of growth.
From the outside, all three organisations appear to be entering the same market.
Internally, they are solving very different problems.
This is one reason experienced multinational leaders often spend less time discussing headcount and more time discussing capability. The objective is rarely to replicate a structure from another geography. The objective is to build enough capability, authority and expertise within the market to support what the organisation is trying to achieve.
The challenge becomes even more pronounced as organisations expand further into APAC. Australia may be the first step, but broader regional growth introduces additional complexity. Different healthcare systems, reimbursement environments, regulatory frameworks and commercial dynamics begin influencing organisational design. Leadership structures that worked well in one market may not translate effectively into another. The organisation needs to think carefully about which functions should be duplicated, which should be shared and which should evolve as regional capability grows.
Organisations that navigate this well tend to approach expansion as a capability-building exercise rather than a market-entry project. They understand that geography alone does not determine success. Capability does. The market opportunity may create the reason for expansion, but leadership, expertise and organisational structure usually determine how effectively that opportunity is realised.
The result is often a different sequence of decisions than originally expected. A commercial leader may not be the first appointment. Market access capability may become critical earlier than anticipated. Medical expertise may prove central to organisational credibility. Governance may need to evolve to support regional complexity. The organisation gradually discovers that expansion is teaching it as much about itself as it is about the market.
That is why the most effective multinational expansions rarely begin with the question, “Who should we hire?”
They begin with a different question.
“What capability must exist within this market for the organisation to succeed here?”
Once that answer becomes clear, the appointments tend to follow naturally.
Build capability before complexity arrives
Whether you are establishing a presence in Australia, strengthening an existing operation or expanding across APAC, the most important decision is often not the next hire. It is understanding what capability the organisation needs close to the market and what should evolve as the business grows.
About Hunton Executive
Executive search, strategic headhunting, and specialist recruitment for healthcare and life sciences organisations. From Board appointments and executive leadership to the specialist capability around them. Permanent, interim and fractional.